Hybio Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hybio Pharmaceutical Co Ltd with three other
companies in this sector in China:
Jinhe Biotechnology Co Ltd
sales of 1.46 billion Chinese Renmimbi [US$230.05 million]
of which 67%
was Medical Feeds Additives),
Beijing Science Sun Pharmaceutical Co Ltd
(749.99 million Chinese Renmimbi [US$118.39 million]
of which 100%
was Phamaceutical Manufacturing Industry), and
Zhejiang Jolly Pharmaceutical Co Ltd
(793.91 million Chinese Renmimbi [US$125.32 million]
of which 75%
Hybio Pharmaceutical Co Ltd reported sales of 1.25 billion Chinese Renmimbi (US$196.72 million)
December of 2017.
increase of 45.8%
versus 2016, when the company's sales were 855.05 million Chinese Renmimbi.
Sales at Hybio Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 451%).